HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study
about
Iron-chelating therapy with deferasirox in transfusion-dependent, higher risk myelodysplastic syndromes: a retrospective, multicentre study.Labile plasma iron levels predict survival in patients with lower-risk Myelodysplastic syndromes.Beyond Human Leukocyte Antigen Class I Antigens: Hereditary Hemochromatosis Gene Mutations in Recurrent Aphthous Oral Ulcers and Behçet Disease in the South of Tunisia.
P2860
HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
HFE gene mutation and oxidativ ...... vational cross-sectional study
@ast
HFE gene mutation and oxidativ ...... vational cross-sectional study
@en
type
label
HFE gene mutation and oxidativ ...... vational cross-sectional study
@ast
HFE gene mutation and oxidativ ...... vational cross-sectional study
@en
prefLabel
HFE gene mutation and oxidativ ...... vational cross-sectional study
@ast
HFE gene mutation and oxidativ ...... vational cross-sectional study
@en
P2093
P2860
P1433
P1476
HFE gene mutation and oxidativ ...... vational cross-sectional study
@en
P2093
Fabíola Fernandes Heredia
Geane Felix De Souza
Juliana Cordeiro De Sousa
Manoel Ricardo Alves Martins
Rivelilson Mendes De Freitas
Romélia Pinheiro Gonçalves
Ronald Feitosa Pinheiro
Silvia Maria Meira Magalhães
P2860
P304
P356
10.1136/BMJOPEN-2014-006048
P577
2015-04-03T00:00:00Z